ABT-431 -: Adrogolide hydrochloride -: Dopamine D1 agonist -: Antiparkinsonian

被引：0
|
作者：
不详
机构：
来源：
DRUGS OF THE FUTURE | 2000年 / 25卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：844 / 844
页数：1
相关论文
共 50 条
  • [1] Adrogolide hydrochloride -: ABT-431 -: Antiparkinsonian -: Dopamine D1 agonist
    不详
    [J]. DRUGS OF THE FUTURE, 2001, 26 (08) : 795 - 795
  • [2] Adrogolide HCl (ABT-431; DAS-431), a prodrug of the dopamine D1 receptor agonist, A-86929:: Preclinical pharmacology and clinical data
    Giardina, WJ
    Williams, M
    [J]. CNS DRUG REVIEWS, 2001, 7 (03): : 305 - 316
  • [3] Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self administration in humans
    Haney, M
    Collins, ED
    Ward, AS
    Foltin, RW
    Fischman, MW
    [J]. PSYCHOPHARMACOLOGY, 1999, 143 (01) : 102 - 110
  • [4] Effects of the novel D1 dopamine receptor agonist ABT-431 on cocaine self-administration and reinstatement
    Self, DW
    Karanian, DA
    Spencer, JJ
    [J]. NEW MEDICATIONS FOR DRUG ABUSE, 2000, 909 : 133 - 144
  • [5] Efficient process for the cyclization of diastereomeric alcohol to a trans amide in the synthesis of dopamine D1 agonist, ABT-431
    Gupta, AK
    Patel, SR
    Deshpande, MN
    [J]. SYNTHETIC COMMUNICATIONS, 1999, 29 (11) : 1835 - 1841
  • [6] Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans
    M. Haney
    Eric D. Collins
    Amie S. Ward
    Richard W. Foltin
    Marian W. Fischman
    [J]. Psychopharmacology, 1999, 143 : 102 - 110
  • [7] Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease
    Rascol, O
    Nutt, JG
    Blin, O
    Goetz, CG
    Trugman, JM
    Soubrouillard, C
    Carter, JH
    Currie, LJ
    Fabre, N
    Thalamas, C
    Giardina, WJ
    Wright, S
    [J]. ARCHIVES OF NEUROLOGY, 2001, 58 (02) : 249 - 254
  • [8] Pulmonary delivery of a dopamine D-1 agonist, ABT-431, in dogs and humans
    Zheng, YQ
    Marsh, KC
    Bertz, RJ
    El-Shourbagy, T
    Adjei, AL
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 191 (02) : 131 - 140
  • [9] ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease
    Rascol, O
    Blin, O
    Thalamas, C
    Descombes, S
    Soubrouillard, C
    Azulay, P
    Fabre, N
    Viallet, F
    Lafnitzegger, K
    Wright, S
    Carter, JH
    Nutt, JG
    [J]. ANNALS OF NEUROLOGY, 1999, 45 (06) : 736 - 741
  • [10] ABT-431, a selective D1 agonist has efficacy in patients with Parkinson's disease
    Rascol, O
    Blin, O
    Descombes, S
    Soubrouilliard, C
    Fabre, N
    Viallet, F
    Thalamas, C
    Azulay, JP
    Lafnitzegger, K
    Fredrick, E
    Wright, S
    Nutt, J
    [J]. NEUROLOGY, 1997, 48 (03) : 32004 - 32004
12345